Group One Trading
CUE icon

Group One Trading’s Cue Biopharma CUE Stock Holding History

Group One Trading’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.9K Buy
+2,500
New +$56.5K ﹤0.01% 5049
2025
Q2 		– Sell
-400
Closed -$10.9K – 8027
2025
Q1 		$10.9K Sell
400
-210
-34% -$7.8K ﹤0.01% 6199
2024
Q4 		$19.9K Buy
610
+43
+8% +$1.62K ﹤0.01% 5688
2024
Q3 		$12.9K Sell
567
-2,133
-79% -$46.2K ﹤0.01% 5478
2024
Q2 		$100K Sell
2,700
-623
-19% -$30.8K ﹤0.01% 3958
2024
Q1 		$188K Buy
3,323
+1,456
+78% +$103K ﹤0.01% 3614
2023
Q4 		$148K Buy
1,867
+897
+92% +$64.1K ﹤0.01% 4139
2023
Q3 		$66.9K Buy
970
+227
+31% +$22.2K ﹤0.01% 4830
2023
Q2 		$81.4K Buy
743
+463
+165% +$54.4K ﹤0.01% 4821
2023
Q1 		$30K Sell
280
-23
-8% -$2.19K ﹤0.01% 5238
2022
Q4 		$25.9K Buy
303
+186
+159% +$17K ﹤0.01% 5445
2022
Q3 		$8K Sell
117
-336
-74% -$28.9K ﹤0.01% 6610
2022
Q2 		$34K Sell
453
-10
-2% -$1.17K ﹤0.01% 5885
2022
Q1 		$68K Buy
463
+46
+11% +$9.75K ﹤0.01% 5857
2021
Q4 		$141K Buy
417
+397
+1,985% +$154K ﹤0.01% 5421
2021
Q3 		$9K Sell
20
-13
-39% -$4.54K ﹤0.01% 7536
2021
Q2 		$12K Buy
+33
New +$12.8K ﹤0.01% 7437
2020
Q3 		– Sell
-167
Closed -$123K – 6149
2020
Q2 		$123K Buy
+167
New +$121K ﹤0.01% 3746

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Group One Trading's CUE Position: Q2 2026 in Review

Group One Trading opened a new position in Cue Biopharma (CUE) in Q2 2026: 30 shares worth $947. The stake represents ﹤0.01% of the portfolio and ranks #7193 among its holdings. This is a return to the name: Group One Trading previously reported a position in CUE as recently as Q1 2025.

Group One Trading first reported a position in CUE in Q2 2021 and has held it in 8 quarters since. The position peaked at $36K in Q2 2022. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Group One Trading held 30 shares of Cue Biopharma worth $947 as of Q2 2026.
  • Cue Biopharma was a new Group One Trading position in Q2 2026.
  • Cue Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7193 holding.
  • Group One Trading first reported a position in Cue Biopharma in Q2 2021 and has held it in 8 quarters since.
  • Group One Trading's Cue Biopharma position peaked at $36K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.